#diseases
16 stories tagged "diseases".
Advertise Here
Reach qualified buyersBoost your visibility among pharma sourcing professionals and potential buyers.
- Grow your business with qualified leads
- GDS reports on your ad performance
- Targeted to this product's audience
- Direct enquiries from buyers
- Visibility to pharma professionals
Sun Pharma to present long-term cancer drug data at ESMO 2026
UNLOXCYT was approved by the US Food and Drug Administration (FDA) in 2024 for adults with metastatic or locally advanced cutaneous squamous cell carcinoma
Latest news
Showing 1–12 of 16 storiesNovo's Awiqli® receives FDA approval as the first and only once-weekly insulin for children 10 years of age and older…
Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to…
Novo’s Awiqli® receives FDA approval as the first and only once-weekly insulin for children 10 years of age and older…
Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to…
Small Cell Lung Cancer Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and Route of…
FDA Approval Of First Potential Hep B Cure Comes Amid Heated Vaccine Debate
Body: FDA’s approval this week of the first functional cure for hepatitis B was celebrated by the Hepatitis B Foundation as a significant step…
Sun Pharma’s UNLOXCYT gets NCCN Category 2A recommendation for locally advanced skin cancer
The updated recommendation adds to the drug’s existing Category 2A designation for metastatic cutaneous squamous cell carcinoma
Jemperli Wins Accelerated FDA Approval for a Rectal Cancer Subtype as Most Trial Patients Avoided Surgery
FDA gave Jemperli accelerated approval for dMMR rectal cancer. Most trial patients skipped surgery, but the data are interim. What patients should…
Ryzumvi Eye Drop Wins FDA Approval for Presbyopia, with 27% Reaching the Main Goal in Its Larger Trial
The FDA approved Ryzumvi eye drops for presbyopia in adults. See how the nightly drop works, trial results, side effects, and what remains unknown.
Zilbrysq Autoinjector Wins FDA Approval for Generalized Myasthenia Gravis, but Patients Must Wait Until Early 2027
FDA approved a once-daily Zilbrysq autoinjector for generalized myasthenia gravis. It launches in early 2027 with the same meningococcal infection…
GSK’s Jemperli wins FDA approval for rectal cancer treatment
India lowers prices of 137 anti-cancer drugs
New Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers…
Page 1 of 2
Advertise on PharmaJungle - Free for 30 Days
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
- 30 days of free advertising
- Visibility across all pages
- Performance report with ad insights
- No setup or registration fee
Exclusive introductory offer for new advertisers
Top sources
Post your requirement
Get offers from suppliers
- Reach pharmaceutical suppliers
- Specify quality standard and quantity
- Set your shipping preference
- Receive offers directly
- Listed on our marketplace
Your product details and requirements may be published on the marketplace.
Create a New Buying Request
Fields marked with * are mandatory.